Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma

This study aimed to investigate the treatment strategy, prognostic factors, and risk factors of early death in elderly patients (age ≥ 65 years) with diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Data from elderly patients diagnosed with DLBCL between 2008 and 2014 were collected for a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Cho, Shih-Feng, Liu, Yi-Chang, Hsiao, Hui-Hua, Huang, Chiung-Tang, Tsai, Yu-Fen, Wang, Hui-Ching, Lin, Sheng-Fung, Liu, Ta-Chih
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349600/
https://ncbi.nlm.nih.gov/pubmed/28290477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep44282
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller